AI assistant
Sending…
Catheter Precision, Inc. — Director's Dealing 2026
Jan 20, 2026
35479_dirs_2026-01-20_677e64f1-1d66-4bab-8fa9-63e3aebf8e05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Catheter Precision, Inc. (VTAK)
CIK: 0001716621
Period of Report: 2025-12-31
Reporting Person: JENKINS DAVID A (Chairman of the Board and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Series M Common Stock Purchase Warrant | $1.56 | J | 170000 | Acquired | Common Stock (170000) | Direct | |
| 2025-12-31 | Series M Common Stock Purchase Warrant | $1.56 | J | 170000 | Acquired | Common Stock (170000) | Indirect |
Footnotes
F1: Initial Exercise Date is any time on or after the Stockholder Approval Date.
F2: Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date
F3: Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP
More from Catheter Precision, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 18
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12